ArticleOpen forum infectious diseases2021

Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis.

Elena G Gibson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.